Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

Схожие документы

• Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
  по: Akiyama, Matthew J., et al.
  Опубликовано: (2018)
• Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
  по: Pericot-Valverde, Irene, et al.
  Опубликовано: (2020)
• Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial
  по: Akiyama, Matthew J., et al.
  Опубликовано: (2019)
• Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
  по: Pericot-Valverde, Irene, et al.
  Опубликовано: (2020)
• Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy
  по: Akiyama, Matthew J, et al.
  Опубликовано: (2020)